Boston Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-8,315
Closed -$810K 616
2019
Q2
$810K Buy
+8,315
New +$759K 0.04% 407
2017
Q3
Sell
-2,449
Closed -$217K 658
2017
Q2
$217K Buy
+2,449
New +$207K 0.01% 620
2016
Q4
Sell
-4,306
Closed -$372K 656
2016
Q3
$372K Sell
4,306
-146
-3% -$12.7K 0.01% 569
2016
Q2
$386K Buy
4,452
+154
+4% +$12.5K 0.01% 540
2016
Q1
$322K Sell
4,298
-9
-0.2% -$678 0.01% 564
2015
Q4
$331K Buy
4,307
+416
+11% +$31.3K 0.01% 555
2015
Q3
$260K Sell
3,891
-2,386
-38% -$176K 0.01% 693
2015
Q2
$465K Sell
6,277
-9,697
-61% -$741K 0.02% 491
2015
Q1
$1.25M Buy
15,974
+8,948
+127% +$678K 0.05% 263
2014
Q4
$507K Sell
7,026
-75
-1% -$5.21K 0.02% 337
2014
Q3
$440K Buy
7,101
+600
+9% +$38.1K 0.02% 362
2014
Q2
$415K Sell
6,501
-224
-3% -$13.6K 0.02% 390
2014
Q1
$414K Sell
6,725
-100
-1% -$5.83K 0.02% 374
2013
Q4
$392K Buy
+6,825
New +$387K 0.02% 386

Other funds holding MDT

Boston Advisors's MDT Position: Q3 2019 in Review

Boston Advisors sold out of Medtronic (MDT) in Q3 2019, closing a stake of 8,315 shares — an estimated $810K sold.

Boston Advisors first reported a position in MDT in Q4 2013 and held it in 14 quarters. The position peaked at $1.25M in Q1 2015. 1,644 funds tracked by Wall St. Rank hold MDT as of Q3 2019.

  • Boston Advisors reported no remaining Medtronic position as of Q3 2019 after selling out during the quarter.
  • Boston Advisors sold 8,315 Medtronic shares in Q3 2019, an estimated $810K.
  • Boston Advisors first reported a position in Medtronic in Q4 2013 and held it in 14 quarters.
  • Boston Advisors's Medtronic position peaked at $1.25M in Q1 2015.
  • 1,644 funds tracked by Wall St. Rank held Medtronic as of Q3 2019.

Based on Boston Advisors's 13F filing for Q3 2019, filed 5 Nov 2019.